MX2019007490A - Composicion que contiene acido n-acetildiamino butirico. - Google Patents

Composicion que contiene acido n-acetildiamino butirico.

Info

Publication number
MX2019007490A
MX2019007490A MX2019007490A MX2019007490A MX2019007490A MX 2019007490 A MX2019007490 A MX 2019007490A MX 2019007490 A MX2019007490 A MX 2019007490A MX 2019007490 A MX2019007490 A MX 2019007490A MX 2019007490 A MX2019007490 A MX 2019007490A
Authority
MX
Mexico
Prior art keywords
containing composition
acetyldiaminobutyric acid
acetyldiaminobutyric
acid
composition
Prior art date
Application number
MX2019007490A
Other languages
English (en)
Inventor
Bilstein Andreas
Original Assignee
Bitop Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bitop Ag filed Critical Bitop Ag
Publication of MX2019007490A publication Critical patent/MX2019007490A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • A01N1/0205Chemical aspects
    • A01N1/021Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • A01N1/0205Chemical aspects
    • A01N1/021Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/007Preparations for dry skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Abstract

La invención se relaciona a una composición que contiene ácido N-acetildiaminobutírico, una sal o un éster de ácido N- acetildiaminobutírico para la aplicación en un método para el tratamiento del cuerpo humano o animal.
MX2019007490A 2016-12-22 2017-12-22 Composicion que contiene acido n-acetildiamino butirico. MX2019007490A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102016125414.2A DE102016125414A1 (de) 2016-12-22 2016-12-22 Zusammensetzung enthaltend N-Acetyldiaminobuttersäure
PCT/EP2017/084454 WO2018115475A2 (de) 2016-12-22 2017-12-22 Zusammensetzung enthaltend n-acetyldiaminobuttersäure

Publications (1)

Publication Number Publication Date
MX2019007490A true MX2019007490A (es) 2019-12-11

Family

ID=62186383

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019007490A MX2019007490A (es) 2016-12-22 2017-12-22 Composicion que contiene acido n-acetildiamino butirico.

Country Status (7)

Country Link
US (1) US20190380985A1 (es)
EP (1) EP3558287A2 (es)
CN (1) CN110461321A (es)
BR (1) BR112019012788A2 (es)
DE (1) DE102016125414A1 (es)
MX (1) MX2019007490A (es)
WO (1) WO2018115475A2 (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993003714A2 (en) * 1991-08-27 1993-03-04 The Upjohn Company Method for treatment of metabolic disorders
DE10222561B4 (de) 2002-05-17 2009-12-10 Dr. Franz Köhler Chemie GmbH Protektive Lösung zur Verhinderung von Ischämieschäden
DE10330243A1 (de) 2003-07-03 2005-01-20 bitop Aktiengesellschaft für biotechnische Optimierung Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von Arzneimitteln zur äusserlichen Behandlung der Neurodermitis
DE102006056766A1 (de) 2006-12-01 2008-06-05 Bitop Ag Verwendung von kompatiblen Soluten
ES2700613T3 (es) 2008-07-16 2019-02-18 Bitop Ag Síntesis de amidinas cíclicas

Also Published As

Publication number Publication date
CN110461321A (zh) 2019-11-15
WO2018115475A2 (de) 2018-06-28
BR112019012788A2 (pt) 2019-12-03
WO2018115475A3 (de) 2018-08-23
EP3558287A2 (de) 2019-10-30
DE102016125414A1 (de) 2018-06-28
US20190380985A1 (en) 2019-12-19

Similar Documents

Publication Publication Date Title
PH12017501033A1 (en) Oral care compositions and methods of use
EP3180009A4 (en) Zoledronic acid dosage forms for the treatment of pain
MX2021007268A (es) Formas solidas de acido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acetico, composiciones, y usos de las mismas.
MX2017013805A (es) Composiciones de acido obeticolico y metodos de uso.
EP4282479A3 (en) Use of pridopidine to treat depression or anxiety
HK1245641A1 (zh) 次氯酸製劑及治療皮膚病的方法
WO2015197193A3 (en) New use for jnk inhibitor molecules for treatment of various diseases
MX2020006237A (es) Compuestos para el tratamiento de enfermedades relacionadas con la expresion de dux4.
MX2018002731A (es) Proceso para la elaboracion de esteres de cianohidrina que contienen fosforo.
PH12017502069A1 (en) Method for treating coffee rust, citrus black spot, citrus scab and banana black sigatoka diseases
IL267603A (en) Automated process for the production of animal and human tissues for implants
MX2018002730A (es) Proceso para producir esteres de cianhidrina que contienen fosforo.
MX2018002729A (es) Proceso para la elaboracion de esteres de cianohidrina que contienen fosforo.
HK1248756A1 (zh) 乳酸菌及其用於治療乳腺炎的用途
PH12016501326A1 (en) (s)-3'-methyl-abscisic acid and esters thereof
TW201613569A (en) Composition consisting of kukoamine A and/or kukoamine B and method of using thereof
MX2018002726A (es) Proceso para producir esteres de cianhidrina que contienen fosforo.
EP3475442A4 (en) 12 (S) -HYDROXYEICOSATRIENOIC ACID COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS
MX2019007490A (es) Composicion que contiene acido n-acetildiamino butirico.
GB2550750A (en) Anthelmintic compounds
GB2535586B (en) A method for computer-assisted analysis of one or more tissue sections of the human or animal body
MX2016017321A (es) Combinacicones y metodos para el tratamiento de dolor neuropatico.
MX2018004532A (es) Combinacion de trazodona y gabapentina para el tratamiento de dolor.
MY174186A (en) Use of an isopropanol-containing solution to combat caliciviridae
EP3250166A4 (en) Process for restoring responsiveness to medication in tissue of living organisms